Delaney Dennis R Abb Vie Inc. Transaction History

Delaney Dennis R

$184 Million
Q2 2024

A detailed history of Delaney Dennis R transactions in Abb Vie Inc. stock. As of the latest transaction made, Delaney Dennis R holds 15,412 shares of ABBV stock, worth $3.09 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

15,412

Previous 15,412 -0.0%

Holding current value

$3.09 Million

Previous $2.81 Million 5.81%

% of portfolio

1.44%

Previous 1.54%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $5,504 - $6,198	-40 Reduced 0.26%	15,412 $2.39 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $5,343 - $6,186	-40 Reduced 0.26%	15,452 $2.3 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $621,736 - $773,710	4,692 Added 43.44%	15,492 $2.09 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $57,844 - $66,616	400 Added 3.85%	10,800 $1.72 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $342,235 - $392,521	-2,550 Reduced 19.69%	10,400 $1.4 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $14,674 - $19,636	-200 Reduced 1.52%	12,950 $1.27 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $6,450 - $9,779	-100 Reduced 0.75%	13,150 $1 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $16,425 - $20,995	-250 Reduced 1.85%	13,250 $964,000
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $19,285 - $22,697	-250 Reduced 1.82%	13,500 $1.09 Million
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $155,592 - $172,970	-1,750 Reduced 11.29%	13,750 $1.3 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $127,936 - $151,377	-1,425 Reduced 8.42%	15,500 $1.44 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $37,724 - $50,516	-410 Reduced 2.37%	16,925 $1.6 Million
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $1.55 Million - $1.7 Million	17,335	17,335 $1.68 Million

Others Institutions Holding ABBV

# of Institutions

3,783

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Delaney Dennis R, based on Form 13F filings with the SEC.

News

Stay updated on Delaney Dennis R with notifications on news.

Account